Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Avanos Medical ( (AVNS) ) has shared an update.
On March 6, 2026, Avanos Medical, Inc.’s board of directors approved an increase in the target value of the annual long-term incentive grant for Chief Executive Officer David C. Pacitti. Under the company’s 2021 Long Term Incentive Plan, his target award will rise from $5,000,000 to $5,500,000 beginning in 2026, signaling the board’s strengthened commitment to executive retention and alignment with shareholder interests.
The adjustment in Pacitti’s equity-based compensation underscores Avanos Medical’s use of long-term incentives to reward leadership performance and support strategic objectives. This move may influence executive compensation benchmarks within the medical technology sector and reflects the company’s confidence in its current CEO’s role in driving future operational and financial outcomes.
The most recent analyst rating on (AVNS) stock is a Hold with a $15.00 price target. To see the full list of analyst forecasts on Avanos Medical stock, see the AVNS Stock Forecast page.
Spark’s Take on AVNS Stock
According to Spark, TipRanks’ AI Analyst, AVNS is a Neutral.
The score is held back primarily by weak/volatile profitability and a negative P/E, partially offset by a solid balance sheet and currently positive cash flow. Technically, the stock trend is constructive (above major moving averages with positive MACD). Earnings call guidance is encouraging, but tariffs are a notable near-term margin headwind; recent governance actions provide modest additional support.
To see Spark’s full report on AVNS stock, click here.
More about Avanos Medical
Avanos Medical, Inc. is a medical technology company operating in the healthcare industry. It focuses on developing and providing advanced medical devices and therapies aimed at improving patient outcomes across various care settings.
Average Trading Volume: 596,225
Technical Sentiment Signal: Sell
Current Market Cap: $623.1M
Learn more about AVNS stock on TipRanks’ Stock Analysis page.